Management of moderate-to-severe dry eye disease using chitosan-N-acetylcysteine (Lacrimera®) eye drops: a retrospective case series

PURPOSE: Dry eye disease is a highly prevalent condition that causes tear film instability, ocular discomfort, and visual disturbance. Lacrimera eye drops are approved for the short-term treatment of dry eye disease. We aimed to evaluate the clinical outcome of patients with moderate-to-severe dry e...

Descripción completa

Detalles Bibliográficos
Autores principales: Nepp, Johannes, Knoetzl, Wolfgang, Prinz, Anna, Hoeller, Sonja, Prinz, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242486/
https://www.ncbi.nlm.nih.gov/pubmed/32124131
http://dx.doi.org/10.1007/s10792-020-01324-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242486/
https://www.ncbi.nlm.nih.gov/pubmed/32124131
http://dx.doi.org/10.1007/s10792-020-01324-5

Ejemplares similares